Search for
Foot Swelling - Large Biopsy 3-6 cm
Biopsy
Report in 288Hrs
At Home
No Fasting Required
Details
Tissue biopsy of swellings.
₹666₹951
30% OFF
Foot Swelling - Large Biopsy 3-6 cm
- Why is it done?
- This test involves a tissue biopsy of 3-6 cm from the foot to obtain a sample for histopathological examination when foot swelling (edema) persists or presents with atypical features
- Diagnose underlying causes of chronic foot edema including malignancy, infection, lymphatic obstruction, or connective tissue disorders
- Identify suspicious skin lesions, nodules, or masses associated with foot swelling that may indicate malignancy or systemic disease
- Evaluate for dermatologic conditions such as lipodermatosclerosis, lymphedema, or inflammatory skin diseases causing foot swelling
- Performed when imaging and serologic tests have been inconclusive in determining the etiology of persistent foot edema
- Assess for infection, vascular compromise, or tissue necrosis in patients with complicated foot swelling
- Normal Range
- Normal findings: Absence of malignancy, normal skin architecture without evidence of inflammation, infection, or pathologic changes
- Histology interpretation: Results are qualitative, reported as either benign or malignant with specific histopathological diagnoses
- Normal skin components should include: epidermis with normal keratinization, dermis with appropriate collagen organization, normal vasculature, and absence of abnormal inflammatory infiltrate
- Units: Tissue specimen description with histologic grading where applicable (grade 1-4 for certain conditions)
- Negative result: No evidence of malignancy or significant pathology; benign diagnosis confirmed
- Positive/Abnormal result: Presence of malignancy, infection, or specific pathologic diagnosis requiring clinical correlation and treatment planning
- Interpretation
- Benign Findings: Indicates no malignancy present; confirms inflammatory, infectious, or vascular etiology of foot swelling
- Malignant Findings: Confirms neoplastic process; specific diagnosis guides oncologic management and prognosis
- Infectious Organisms: Bacteria, fungi, or parasites identified via staining and culture guide antimicrobial therapy selection
- Inflammatory/Autoimmune Changes: Granulomatous inflammation, vasculitis, or lymphocytic infiltration suggests systemic disease requiring immunosuppressive therapy
- Vascular/Lymphatic Changes: Dilated lymphatic channels, fibrosis, or vascular abnormalities explain chronic edema pathophysiology
- Factors Affecting Results: Specimen quality, fixation time, sampling location, patient skin preparation, and processor technique can influence diagnostic accuracy
- Clinical Significance: Results directly inform treatment decisions, prognosis assessment, and need for additional imaging or laboratory testing
- Associated Organs
- Primary Systems: Integumentary system (skin), lymphatic system, vascular system, and musculoskeletal system
- Conditions Associated with Abnormal Results: Melanoma, squamous cell carcinoma, lymphomas, cellulitis, erysipelas, diabetic ulcers with infection, lymphedema, lipodermatosclerosis
- Diseases Diagnosed: Skin malignancies, lymphatic obstruction from metastatic disease, venous insufficiency, chronic infections, connective tissue disorders (lupus, scleroderma), granulomatous infections (tuberculosis, sarcoidosis)
- Related Systemic Involvement: Liver cirrhosis causing protein malnutrition, renal disease with hypoalbuminemia, cardiac dysfunction with decreased oncotic pressure, malignancy with lymph node involvement
- Potential Complications: Infection at biopsy site, bleeding or hematoma formation, delayed wound healing, hypertrophic scarring, neuropathic pain, cellulitis progression, cosmetic concerns
- Follow-up Tests
- If Malignancy Confirmed: Staging CT/MRI, PET scan, sentinel lymph node biopsy, immunohistochemistry panels, genetic testing for mutations, additional dermatologic evaluation
- If Infection Identified: Blood cultures, sensitivity testing for antibiotic selection, imaging to assess for abscess or deep tissue involvement, Doppler ultrasound for vascular compromise
- If Inflammatory/Autoimmune Disease: Serum ANA, rheumatoid factor, ESR/CRP, specific antibodies (ANCA for vasculitis), additional biopsies if systemic disease suspected
- If Lymphatic/Vascular Abnormality: Lymphoscintigraphy, venography, compression ultrasound, measurement of limb circumference, assessment for lymphedema staging
- Monitoring Frequency: Malignancy - every 3-6 months for first 2 years, then annually; Lymphedema - ongoing physical therapy reassessment; Infection - daily monitoring during treatment, weekly after resolution
- Related Complementary Tests: Complete metabolic panel, albumin/protein levels, prothrombin time, CBC with differential, D-dimer, liver function tests, thyroid function tests
- Fasting Required?
- Fasting: No fasting required for the biopsy procedure itself
- Pre-procedure Preparation: Shower or bathe the foot 24 hours before procedure with antimicrobial soap; avoid moisturizers or topical medications on biopsy site for 24 hours
- Medications to Avoid: Aspirin and NSAIDs - discontinue 3-5 days before procedure (increases bleeding risk); anticoagulants (warfarin, DOACs) - consult physician regarding temporary discontinuation; antiplatelet agents - may need adjustment
- Other Preparation: Wear loose, comfortable clothing; bring insurance information and identification; arrange transportation if sedation used; avoid strenuous activity 24-48 hours after biopsy; elevate foot for 24 hours post-procedure
- Allergies/Contraindications: Inform provider of local anesthetic allergies (lidocaine hypersensitivity); report anticoagulation therapy, bleeding disorders, or immunocompromised status
- Post-procedure Instructions: Keep biopsy site clean and dry; change dressing daily or as instructed; monitor for signs of infection (increasing redness, warmth, drainage, fever); avoid soaking foot in water for 7-10 days; remove sutures as directed (typically 7-14 days)
How our test process works!
